Newsletter
American Association Of Physicists In Medicine VOLUME 28 NO. 5
SEPTEMBER/OCTOBER 2003
AAPM President’s Column Martin S. Weinhous Cleveland, Ohio
Follow-ups In my last column I raised two very important issues. The first was in regard to the ACMP and the second in regard to the forthcoming AAPM/NCRP shielding reports.
Follow-up, ACMP
Catching Up Like many of you, I’ve just returned from the very successful AAPM Meeting in San Diego. This newsletter’s submission deadline, August 15th, overlapped with the end of the meeting. OK, I am submitting a bit late and thus this will be a very brief report. . .
Credits AAPM’s Headquarters staff, Meeting Coordination Committee members, and Local Arrangements Committee members are all to be congratulated for the quality of the meeting and for the smoothness with which it operated. They even arranged for wonderful weather.
The time has come for medical physicists to each, individually, make their own decision about joining the ACMP. Fencesitting only delays strategic planning for both the ACMP and AAPM. So, once again, learn what the ACMP might mean to you and join, or not, but at least make and act upon your decision.
Clinical Trials Update: Report from the Subcommittee on QA of Clinical Trials The RTOG H-0022 Protocol Geoffrey S. Ibbott Subcommittee Chair Most medical physicists are aware that the National Cancer Institute sponsors clinical trials that are conducted by cooperative clinical study groups. However, many medical physicists are unaware of how pervasive such trials are, and whether or not their institutions participate in such trials. The chances are they do, as (See Ibbott - p. 3)
Follow-up, NCRP Progress has been made with the NCRP and we may have a resolution to the quartering issue. That is, the NCRP is in the process of approving language to appear in both of the joint shielding reports that would state that the annual effective dose limit for the general public exposed around medical facilities shall be 1 mSv. (That shielding shall be designed to achieve 1 mSv.) Further there will be no mention of quartering of that limit, i.e. of us(See Weinhous - p. 3)
TABLE OF CONTENTS Summer School Exec. Dir’s. Column Gov’t. Affairs Column CARE Bill CLA Subcomm. Rep. Chapter News Announcements Memorial Members List Mammography FAQs Letters to the Editor
p 5 p 6 p 7 p 8 p 10 p 12 p 14 p 15 p 16 p 18 p 20